Mounjaro is a brand-name prescription medication that contains the active ingredient tirzepatide [1]. It is an injectable medication used for the treatment of type 2 diabetes [1]. Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it works by mimicking the actions of two naturally occurring hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) [1][2]. These hormones help to regulate blood sugar levels [1].
What does Mounjaro do for blood sugar?
Mounjaro helps to lower blood sugar by increasing insulin secretion from the pancreas, decreasing the amount of sugar produced by the liver, and slowing down the emptying of food from the stomach [1]. This dual action makes it an effective treatment for improving glycemic control in adults with type 2 diabetes [1].
Is Mounjaro approved for weight loss?
While Mounjaro is primarily indicated for type 2 diabetes management, tirzepatide has also shown significant weight loss effects in clinical trials. The U.S. Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults who are overweight or obese, or who have at least one weight-related condition, under the brand name Zepbound [3][4]. This approval was granted in November 2023 [3].
When does Mounjaro's patent expire?
Patent information for Mounjaro and its active ingredient, tirzepatide, can be complex and may involve multiple patents covering different aspects of the drug, such as formulation, manufacturing, and methods of use [5]. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity [5]. Generally, brand-name drugs have patent protection for a period, after which generic versions may become available. For tirzepatide, various patents are listed, with some expiring in the coming years [5].
Who manufactures Mounjaro?
Mounjaro is manufactured by Eli Lilly and Company [1].
How is Mounjaro administered?
Mounjaro is administered as a once-weekly subcutaneous injection [1]. It is available in several dosage strengths [1]. Patients are typically instructed on how to administer the injection themselves [1].